Mimedx Group logo

Mimedx Group share price today

(MDXG)

Mimedx Group share price is $8.91 & ₹764.57 as on 7 Jan 2025, 2.30 'hrs' IST

$8.91

-0.28

(-3.05%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Mimedx Group share price in Dollar and Rupees. Guide to invest in Mimedx Group stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mimedx Group, along with analyst recommendations, forecasts, and comprehensive financials.

Mimedx Group share price movements

  • Today's Low: $8.82
    Today's High: $9.33

    Day's Volatility :5.52%

  • 52 Weeks Low: $5.47
    52 Weeks High: $10.14

    52 Weeks Volatility :46.06%

Mimedx Group Returns

PeriodMimedx Group, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
64.11%
-8.4%
0.0%
6 Months
34.55%
-3.8%
0.0%
1 Year
11.8%
-0.1%
0.0%
3 Years
68.01%
2.9%
-19.8%

Mimedx Group Key Statistics

in dollars & INR

Previous Close
$9.19
Open
$9.17
Today's High
$9.33
Today's Low
$8.815
Market Capitalization
$1.4B
Today's Volume
$470.4K
52 Week High
$10.14
52 Week Low
$5.47
Revenue TTM
$342.8M
EBITDA
$67.5M
Earnings Per Share (EPS)
$0.57
PE Ratio
16.88
Profit Margin
25.8%
Quarterly Earnings Growth YOY
-0.1%
Return On Equity TTM
62.47%

How to invest in Mimedx Group from India?

It is very easy for Indian residents to invest directly in Mimedx Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mimedx Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mimedx Group or MDXG on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mimedx Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mimedx Group shares which would translate to 0.096 fractional shares of Mimedx Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mimedx Group, in just a few clicks!

Returns in Mimedx Group for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mimedx Group investment value today

Current value as on today

₹1,11,617

Returns

₹11,617

(+11.62%)

Returns from Mimedx Group Stock

₹8,394 (+8.39%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Mimedx Group

0%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Mimedx Group on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 0% more investors are searching Mimedx Group in the last 30 days versus the previous period.

Global Institutional Holdings in Mimedx Group

  • Essex Woodlands Health Ventures

    19.19%

  • BlackRock Inc

    6.34%

  • Trigran Investments Inc

    5.23%

  • Vanguard Group Inc

    4.74%

  • Paradigm Capital Management, Inc.

    3.17%

  • State Street Corp

    2.63%

Analyst Recommendation on Mimedx Group

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Mimedx Group(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Mimedx Group

What analysts predicted

Upside of 50.39%

Current:

$8.91

Target:

$13.40

Insights on Mimedx Group

  • Price Movement

    In the last 7 days, MDXG stock has moved down by -3.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 87.20M → 84.05M (in $), with an average decrease of 3.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 17.62M → 8.09M (in $), with an average decrease of 54.1% per quarter
  • MDXG vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 5.9%
  • Price to Sales

    ForMDXG every $1 of sales, investors are willing to pay $3.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Mimedx Group Financials in INR & Dollars

FY18Y/Y Change
Revenue
$359.1M
↑ 11.82%
Net Income
$-30.0M
↓ 146.32%
Net Profit Margin
-8.35%
↓ 28.51%
FY19Y/Y Change
Revenue
$359.1M
↑ 0.0%
Net Income
$-30.0M
↑ 0.0%
Net Profit Margin
-8.35%
↑ 0.0%
FY20Y/Y Change
Revenue
$248.2M
↓ 30.88%
Net Income
$-49.3M
↑ 64.4%
Net Profit Margin
-19.85%
↓ 11.5%
FY21Y/Y Change
Revenue
$258.6M
↑ 4.18%
Net Income
$-10.3M
↓ 79.13%
Net Profit Margin
-3.98%
↑ 15.87%
FY22Y/Y Change
Revenue
$267.8M
↑ 3.57%
Net Income
$-30.2M
↑ 193.6%
Net Profit Margin
-11.27%
↓ 7.29%
FY23Y/Y Change
Revenue
$321.5M
↑ 20.03%
Net Income
$67.4M
↓ 323.33%
Net Profit Margin
20.98%
↑ 32.25%
Q2 FY23Q/Q Change
Revenue
$81.3M
↑ 13.37%
Net Income
$1.2M
↓ 124.08%
Net Profit Margin
1.48%
↑ 8.43%
Q3 FY23Q/Q Change
Revenue
$81.7M
↑ 0.56%
Net Income
$6.8M
↑ 463.42%
Net Profit Margin
8.27%
↑ 6.79%
Q4 FY23Q/Q Change
Revenue
$86.8M
↑ 6.27%
Net Income
$62.7M
↑ 827.2%
Net Profit Margin
72.19%
↑ 63.92%
Q1 FY24Q/Q Change
Revenue
$84.7M
↓ 2.44%
Net Income
$9.3M
↓ 85.23%
Net Profit Margin
10.93%
↓ 61.26%
Q2 FY24Q/Q Change
Revenue
$87.2M
↑ 2.95%
Net Income
$17.6M
↑ 90.31%
Net Profit Margin
20.21%
↑ 9.28%
Q3 FY24Q/Q Change
Revenue
$84.1M
↓ 3.61%
Net Income
$8.1M
↓ 54.07%
Net Profit Margin
9.63%
↓ 10.58%
FY18Y/Y Change
Profit
$322.7M
↑ 12.87%
FY19Y/Y Change
Profit
$322.7M
↑ 0.0%
FY20Y/Y Change
Profit
$208.9M
↓ 35.27%
FY21Y/Y Change
Profit
$215.3M
↑ 3.08%
FY22Y/Y Change
Profit
$219.5M
↑ 1.95%
FY23Y/Y Change
Profit
$266.8M
↑ 21.55%
Q2 FY23Q/Q Change
Profit
$67.7M
↑ 14.2%
Q3 FY23Q/Q Change
Profit
$66.9M
↓ 1.11%
Q4 FY23Q/Q Change
Profit
$73.0M
↑ 9.07%
Q1 FY24Q/Q Change
Profit
$71.5M
↓ 2.0%
Q2 FY24Q/Q Change
Profit
$72.2M
↑ 0.88%
Q3 FY24Q/Q Change
Profit
$68.7M
↓ 4.75%
FY18Y/Y Change
Operating Cash Flow
$35.8M
↓ 43.13%
Investing Cash Flow
$-9.2M
↑ 70.84%
Financing Cash Flow
$-8.9M
↓ 85.21%
FY19Y/Y Change
Operating Cash Flow
$35.8M
↑ 0.0%
Investing Cash Flow
$504.0K
↓ 105.47%
Financing Cash Flow
$-8.9M
↑ 0.0%
FY20Y/Y Change
Operating Cash Flow
$-39.4M
↓ 210.1%
Investing Cash Flow
$-4.6M
↓ 1003.77%
Financing Cash Flow
$62.9M
↓ 803.59%
FY21Y/Y Change
Operating Cash Flow
$-2.0M
↓ 94.97%
Investing Cash Flow
$-3.4M
↓ 25.47%
Financing Cash Flow
$-3.4M
↓ 105.33%
FY22Y/Y Change
Operating Cash Flow
$-17.9M
↑ 802.77%
Investing Cash Flow
$-2.7M
↓ 21.65%
Financing Cash Flow
$-580.0K
↓ 82.7%
Q2 FY23Q/Q Change
Operating Cash Flow
$7.8M
↓ 292.07%
Investing Cash Flow
$-348.0K
↓ 48.6%
Financing Cash Flow
$4.0K
↓ 200.0%

Mimedx Group Technicals Summary

Sell

Neutral

Buy

Mimedx Group is currently in a neutral trading position according to technical analysis indicators.

Mimedx Group Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mimedx Group, Inc.
-3.97%
34.55%
11.8%
68.01%
27.11%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mimedx Group, Inc.
16.88
16.88
2.97
0.28
0.62
0.18
NA
1.23
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mimedx Group, Inc.
Buy
$1.4B
27.11%
16.88
25.8%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Mimedx Group

mimedx® is an industry leader in advanced wound care and a therapeutic biologics company developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. the company processes the human placental tissue utilizing its proprietary purion® process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization. mimedx has supplied more than two million allografts, through both direct and consignment shipments. for additional information, please visit www.mimedx.com.
Organization
Mimedx Group
Employees
895
CEO
Mr. Joseph H. Capper
Industry
Biotechnology

Management People of Mimedx Group

NameTitle
Mr. Joseph H. Capper
CEO & Director
Mr. Douglas C. Rice CPA
Chief Financial Officer
Mr. William F. Hulse IV
General Counsel & Chief Administrative Officer
Mr. Scott M. Turner
Senior Vice President of Operations & Procurement
Mr. Matthew M. Notarianni
Head of Investor Relations
Mr. Mark P. Graves
Senior VP & Chief Compliance Officer
Ms. Hilary Dixon
Vice President of Investor Relations & Corporate Strategic Communications
Ms. Kate Surdez
Chief Human Resources Officer
Dr. David H. Mason Jr.
Chief Medical Officer
Dr. Robert Benjamin Stein M.D., Ph.D.
President of Regenerative Medicine & Biologics Innovation

Important FAQs about investing in Mimedx Group from India :

What is Mimedx Group share price today?

Mimedx Group share price today stands at $8.91, Open: $9.17 ; Previous Close: $9.19 ; High: $9.33 ; Low: $8.82 ; 52 Week High: $10.14 ; 52 Week Low: $5.47. The stock opens at $9.17, after a previous close of $9.19. The stock reached a daily high of $9.33 and a low of $8.82, with a 52-week high of $10.14 and a 52-week low of $5.47.

Can Indians buy Mimedx Group shares?

Yes, Indians can invest in the Mimedx Group (MDXG) from India.

With INDmoney, you can buy Mimedx Group at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mimedx Group at zero transaction cost.

How can I buy Mimedx Group shares from India?

It is very easy to buy Mimedx Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mimedx Group be purchased?

Yes, you can buy fractional shares of Mimedx Group with INDmoney app.

What are the documents required to start investing in Mimedx Group stocks?

To start investing in Mimedx Group, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mimedx Group

Today’s highest price of Mimedx Group (MDXG) is $9.33.

Today’s lowest price of Mimedx Group (MDXG) is $8.82.

What is today's market capitalisation of Mimedx Group

Today's market capitalisation of Mimedx Group MDXG is 1.4B

What is the 52 Week High and Low Range of Mimedx Group

  • 52 Week High

    $10.14

  • 52 Week Low

    $5.47

What are the historical returns of Mimedx Group?

  • 1 Month Returns

    -3.97%

  • 3 Months Returns

    34.55%

  • 1 Year Returns

    11.8%

  • 5 Years Returns

    27.11%

Who is the Chief Executive Officer (CEO) of Mimedx Group

Mr. Joseph H. Capper is the current Chief Executive Officer (CEO) of Mimedx Group.